nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftriaxone—Prothrombin time shortened—Riluzole—amyotrophic lateral sclerosis	0.115	0.199	CcSEcCtD
Ceftriaxone—GLUL—Astrocytic Glutamate-Glutamine Uptake And Metabolism—SLC1A2—amyotrophic lateral sclerosis	0.0928	0.268	CbGpPWpGaD
Ceftriaxone—GLUL—Astrocytic Glutamate-Glutamine Uptake And Metabolism—SLC1A3—amyotrophic lateral sclerosis	0.0789	0.228	CbGpPWpGaD
Ceftriaxone—Alveolitis allergic—Riluzole—amyotrophic lateral sclerosis	0.0461	0.0799	CcSEcCtD
Ceftriaxone—Haematocrit decreased—Riluzole—amyotrophic lateral sclerosis	0.0323	0.056	CcSEcCtD
Ceftriaxone—Pseudomembranous colitis—Riluzole—amyotrophic lateral sclerosis	0.0242	0.0419	CcSEcCtD
Ceftriaxone—Lymphopenia—Riluzole—amyotrophic lateral sclerosis	0.0235	0.0407	CcSEcCtD
Ceftriaxone—GLUL—peripheral nervous system—amyotrophic lateral sclerosis	0.0156	0.226	CbGeAlD
Ceftriaxone—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.015	0.0259	CcSEcCtD
Ceftriaxone—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.0148	0.0257	CcSEcCtD
Ceftriaxone—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.013	0.0226	CcSEcCtD
Ceftriaxone—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.0128	0.0222	CcSEcCtD
Ceftriaxone—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0199	CcSEcCtD
Ceftriaxone—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0196	CcSEcCtD
Ceftriaxone—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0183	CcSEcCtD
Ceftriaxone—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0176	CcSEcCtD
Ceftriaxone—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00999	0.0173	CcSEcCtD
Ceftriaxone—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00925	0.016	CcSEcCtD
Ceftriaxone—GLUL—hindbrain—amyotrophic lateral sclerosis	0.00914	0.132	CbGeAlD
Ceftriaxone—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00902	0.0156	CcSEcCtD
Ceftriaxone—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00821	0.0142	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00786	0.0136	CcSEcCtD
Ceftriaxone—Cefazolin—PON1—amyotrophic lateral sclerosis	0.00783	1	CrCbGaD
Ceftriaxone—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.0074	0.0128	CcSEcCtD
Ceftriaxone—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00705	0.0122	CcSEcCtD
Ceftriaxone—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00656	0.0114	CcSEcCtD
Ceftriaxone—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00656	0.0114	CcSEcCtD
Ceftriaxone—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00641	0.0111	CcSEcCtD
Ceftriaxone—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00634	0.011	CcSEcCtD
Ceftriaxone—GLUL—Amino acid and derivative metabolism—DAO—amyotrophic lateral sclerosis	0.00631	0.0182	CbGpPWpGaD
Ceftriaxone—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00628	0.0109	CcSEcCtD
Ceftriaxone—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00607	0.0105	CcSEcCtD
Ceftriaxone—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00604	0.0105	CcSEcCtD
Ceftriaxone—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC1A2—amyotrophic lateral sclerosis	0.00575	0.0166	CbGpPWpGaD
Ceftriaxone—GLUL—embryo—amyotrophic lateral sclerosis	0.00571	0.0825	CbGeAlD
Ceftriaxone—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00571	0.0099	CcSEcCtD
Ceftriaxone—Chills—Riluzole—amyotrophic lateral sclerosis	0.00542	0.00939	CcSEcCtD
Ceftriaxone—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC1A2—amyotrophic lateral sclerosis	0.00534	0.0154	CbGpPWpGaD
Ceftriaxone—GLUL—brainstem—amyotrophic lateral sclerosis	0.00524	0.0756	CbGeAlD
Ceftriaxone—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00518	0.00898	CcSEcCtD
Ceftriaxone—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00515	0.00892	CcSEcCtD
Ceftriaxone—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC1A3—amyotrophic lateral sclerosis	0.00489	0.0141	CbGpPWpGaD
Ceftriaxone—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00488	0.00845	CcSEcCtD
Ceftriaxone—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00486	0.00842	CcSEcCtD
Ceftriaxone—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00483	0.00837	CcSEcCtD
Ceftriaxone—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00474	0.00822	CcSEcCtD
Ceftriaxone—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00471	0.00816	CcSEcCtD
Ceftriaxone—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00465	0.00805	CcSEcCtD
Ceftriaxone—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00455	0.0079	CcSEcCtD
Ceftriaxone—GLUL—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00455	0.0132	CbGpPWpGaD
Ceftriaxone—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC1A3—amyotrophic lateral sclerosis	0.00454	0.0131	CbGpPWpGaD
Ceftriaxone—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00442	0.00767	CcSEcCtD
Ceftriaxone—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00429	0.00744	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00429	0.00744	CcSEcCtD
Ceftriaxone—Infection—Riluzole—amyotrophic lateral sclerosis	0.00426	0.00739	CcSEcCtD
Ceftriaxone—GLUL—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.0042	0.0121	CbGpPWpGaD
Ceftriaxone—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.0042	0.00728	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00415	0.00719	CcSEcCtD
Ceftriaxone—GLUL—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00406	0.0117	CbGpPWpGaD
Ceftriaxone—GLUL—TNF alpha Signaling Pathway—CASP9—amyotrophic lateral sclerosis	0.00394	0.0114	CbGpPWpGaD
Ceftriaxone—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00385	0.00668	CcSEcCtD
Ceftriaxone—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00378	0.00655	CcSEcCtD
Ceftriaxone—GLUL—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00371	0.0107	CbGpPWpGaD
Ceftriaxone—Pain—Riluzole—amyotrophic lateral sclerosis	0.00367	0.00636	CcSEcCtD
Ceftriaxone—GLUL—medulla oblongata—amyotrophic lateral sclerosis	0.00365	0.0527	CbGeAlD
Ceftriaxone—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00354	0.00613	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00351	0.00608	CcSEcCtD
Ceftriaxone—GLUL—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00349	0.0101	CbGpPWpGaD
Ceftriaxone—GLUL—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00345	0.00997	CbGpPWpGaD
Ceftriaxone—GLUL—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00345	0.00997	CbGpPWpGaD
Ceftriaxone—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00341	0.00591	CcSEcCtD
Ceftriaxone—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00339	0.00588	CcSEcCtD
Ceftriaxone—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00339	0.00588	CcSEcCtD
Ceftriaxone—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—amyotrophic lateral sclerosis	0.00339	0.00979	CbGpPWpGaD
Ceftriaxone—GLUL—spinal cord—amyotrophic lateral sclerosis	0.00326	0.047	CbGeAlD
Ceftriaxone—GLUL—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00322	0.0093	CbGpPWpGaD
Ceftriaxone—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00548	CcSEcCtD
Ceftriaxone—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—amyotrophic lateral sclerosis	0.00314	0.00909	CbGpPWpGaD
Ceftriaxone—GLUL—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00311	0.00899	CbGpPWpGaD
Ceftriaxone—GLUL—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00308	0.00889	CbGpPWpGaD
Ceftriaxone—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00304	0.00526	CcSEcCtD
Ceftriaxone—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00509	CcSEcCtD
Ceftriaxone—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—amyotrophic lateral sclerosis	0.00288	0.00832	CbGpPWpGaD
Ceftriaxone—GLUL—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00284	0.00822	CbGpPWpGaD
Ceftriaxone—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00284	0.00492	CcSEcCtD
Ceftriaxone—GLUL—nervous system—amyotrophic lateral sclerosis	0.00274	0.0396	CbGeAlD
Ceftriaxone—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00273	0.0079	CbGpPWpGaD
Ceftriaxone—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00273	0.00473	CcSEcCtD
Ceftriaxone—Rash—Riluzole—amyotrophic lateral sclerosis	0.00271	0.00469	CcSEcCtD
Ceftriaxone—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.0027	0.00468	CcSEcCtD
Ceftriaxone—Headache—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00466	CcSEcCtD
Ceftriaxone—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—amyotrophic lateral sclerosis	0.00267	0.00773	CbGpPWpGaD
Ceftriaxone—GLUL—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00264	0.00764	CbGpPWpGaD
Ceftriaxone—GLUL—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00264	0.00764	CbGpPWpGaD
Ceftriaxone—GLUL—central nervous system—amyotrophic lateral sclerosis	0.00264	0.0381	CbGeAlD
Ceftriaxone—GLUL—cerebellum—amyotrophic lateral sclerosis	0.00258	0.0373	CbGeAlD
Ceftriaxone—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00255	0.00442	CcSEcCtD
Ceftriaxone—GLUL—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00236	0.00681	CbGpPWpGaD
Ceftriaxone—GLUL—brain—amyotrophic lateral sclerosis	0.0021	0.0303	CbGeAlD
Ceftriaxone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00208	0.00602	CbGpPWpGaD
Ceftriaxone—SLC22A6—brain—amyotrophic lateral sclerosis	0.00208	0.0301	CbGeAlD
Ceftriaxone—SLC15A2—medulla oblongata—amyotrophic lateral sclerosis	0.00189	0.0272	CbGeAlD
Ceftriaxone—ALB—HDL-mediated lipid transport—APOE—amyotrophic lateral sclerosis	0.00183	0.0053	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00174	0.00503	CbGpPWpGaD
Ceftriaxone—SLC15A2—spinal cord—amyotrophic lateral sclerosis	0.00168	0.0243	CbGeAlD
Ceftriaxone—GLUL—TNF alpha Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.00166	0.0048	CbGpPWpGaD
Ceftriaxone—SLC22A11—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00164	0.00474	CbGpPWpGaD
Ceftriaxone—SLC22A8—nervous system—amyotrophic lateral sclerosis	0.00163	0.0235	CbGeAlD
Ceftriaxone—GLUL—Metabolism—VAPB—amyotrophic lateral sclerosis	0.0016	0.00463	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—TPK1—amyotrophic lateral sclerosis	0.0016	0.00463	CbGpPWpGaD
Ceftriaxone—SLC22A8—central nervous system—amyotrophic lateral sclerosis	0.00157	0.0227	CbGeAlD
Ceftriaxone—SLC15A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00151	0.00437	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—TUBA4A—amyotrophic lateral sclerosis	0.0015	0.00433	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00147	0.00424	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—TUBA4A—amyotrophic lateral sclerosis	0.00143	0.00412	CbGpPWpGaD
Ceftriaxone—SLC15A2—nervous system—amyotrophic lateral sclerosis	0.00142	0.0205	CbGeAlD
Ceftriaxone—SLC15A1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.0014	0.00406	CbGpPWpGaD
Ceftriaxone—SLC22A11—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00139	0.00403	CbGpPWpGaD
Ceftriaxone—SLC15A2—central nervous system—amyotrophic lateral sclerosis	0.00136	0.0197	CbGeAlD
Ceftriaxone—GLUL—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00136	0.00394	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—PFN1—amyotrophic lateral sclerosis	0.00135	0.0039	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.00134	0.00386	CbGpPWpGaD
Ceftriaxone—SLC15A2—cerebellum—amyotrophic lateral sclerosis	0.00133	0.0193	CbGeAlD
Ceftriaxone—ALB—brain—amyotrophic lateral sclerosis	0.0013	0.0187	CbGeAlD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00129	0.00373	CbGpPWpGaD
Ceftriaxone—SLC15A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00129	0.00372	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—PFN1—amyotrophic lateral sclerosis	0.00128	0.00371	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00128	0.0037	CbGpPWpGaD
Ceftriaxone—SLC22A8—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00125	0.00361	CbGpPWpGaD
Ceftriaxone—SLC22A8—brain—amyotrophic lateral sclerosis	0.00125	0.018	CbGeAlD
Ceftriaxone—SLC22A11—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00124	0.00359	CbGpPWpGaD
Ceftriaxone—SLC15A1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00119	0.00345	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00119	0.00345	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—DAO—amyotrophic lateral sclerosis	0.00116	0.00335	CbGpPWpGaD
Ceftriaxone—SLC15A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00115	0.00332	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00111	0.0032	CbGpPWpGaD
Ceftriaxone—SLC15A2—brain—amyotrophic lateral sclerosis	0.00108	0.0156	CbGeAlD
Ceftriaxone—SLC15A1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00106	0.00308	CbGpPWpGaD
Ceftriaxone—SLC22A8—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00106	0.00307	CbGpPWpGaD
Ceftriaxone—ALB—Lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.00105	0.00305	CbGpPWpGaD
Ceftriaxone—SLC22A6—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00104	0.00301	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000985	0.00285	CbGpPWpGaD
Ceftriaxone—SLC22A8—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000947	0.00274	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—SOD1—amyotrophic lateral sclerosis	0.000934	0.0027	CbGpPWpGaD
Ceftriaxone—SLC22A6—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000887	0.00256	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000879	0.00254	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000833	0.00241	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000822	0.00238	CbGpPWpGaD
Ceftriaxone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—amyotrophic lateral sclerosis	0.000821	0.00237	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—GSR—amyotrophic lateral sclerosis	0.000811	0.00234	CbGpPWpGaD
Ceftriaxone—SLC22A6—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00079	0.00228	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000769	0.00222	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.00076	0.0022	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000714	0.00206	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000708	0.00205	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000708	0.00205	CbGpPWpGaD
Ceftriaxone—ALB—Lipid and lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.0007	0.00202	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	0.000689	0.00199	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000666	0.00192	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.000664	0.00192	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000654	0.00189	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000654	0.00189	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—SOD1—amyotrophic lateral sclerosis	0.000652	0.00188	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000635	0.00184	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000631	0.00182	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—amyotrophic lateral sclerosis	0.000621	0.00179	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000607	0.00175	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000607	0.00175	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000604	0.00175	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.000598	0.00173	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000593	0.00171	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000583	0.00168	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000543	0.00157	CbGpPWpGaD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000542	0.00157	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000541	0.00156	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00054	0.00156	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00054	0.00156	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00053	0.00153	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000504	0.00146	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000494	0.00143	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000481	0.00139	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000474	0.00137	CbGpPWpGaD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000461	0.00133	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000451	0.0013	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000451	0.0013	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000427	0.00124	CbGpPWpGaD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000411	0.00119	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000402	0.00116	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	0.000397	0.00115	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	0.000379	0.00109	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000358	0.00103	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000342	0.000989	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000329	0.00095	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000325	0.000939	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000318	0.00092	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000308	0.000891	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000305	0.000882	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.000289	0.000835	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000275	0.000796	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—APOE—amyotrophic lateral sclerosis	0.000271	0.000782	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000264	0.000764	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000264	0.000764	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	0.00026	0.00075	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.000259	0.000749	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	0.000247	0.000715	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000246	0.000712	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000242	0.000698	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000234	0.000677	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000234	0.000677	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.000229	0.000661	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000225	0.000649	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000211	0.00061	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000209	0.000603	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	0.000191	0.000552	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000185	0.000536	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.000176	0.000509	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000149	0.000431	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000145	0.000418	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000134	0.000386	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	0.000134	0.000386	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000122	0.000352	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000115	0.000333	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00011	0.000317	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.0001	0.000289	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	9.08e-05	0.000263	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.86e-05	0.000198	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	5.93e-05	0.000172	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.9e-05	0.00017	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.42e-05	0.000157	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	4.48e-05	0.00013	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	4.46e-05	0.000129	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.05e-05	8.83e-05	CbGpPWpGaD
